您当前所在的位置:首页 > 产品中心 > 产品信息
PD-118057_分子结构_CAS_313674-97-4)
点击图片或这里关闭

PD-118057

产品号 P5624 公司名称 Sigma Aldrich
CAS号 313674-97-4 公司网站 http://www.sigmaaldrich.com
分子式 C21H17Cl2NO2 电 话 1-800-521-8956
分子量 386.27118 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 under inert gas Chembase数据库ID: 153933

产品价格信息

请登录

产品别名

标题
PD-118057
IUPAC标准名
2-({4-[2-(3,4-dichlorophenyl)ethyl]phenyl}amino)benzoic acid
IUPAC传统名
2-({4-[2-(3,4-dichlorophenyl)ethyl]phenyl}amino)benzoic acid
别名
2-[[4-[2-(3,4-Dichlorophenyl)ethyl]phenyl]amino]benzoic acid

产品登记号

MDL号 MFCD08705328
PubChem SID 24724580
CAS号 313674-97-4

产品性质

Empirical Formula (Hill Notation) C21H17Cl2NO2
纯度 ≥98% (HPLC)
外观 light yellow solid
溶解度 DMSO: soluble9 mg/mL
GHS危险品标识 GHS07
GHS警示词 Warning
GHS危险声明 H315-H319-H335-H413
欧盟危险性物质标志 刺激性(Irritant) 刺激性(Irritant) (Xi)
MSDS下载 下载链接
个人保护装置 dust mask type N95 (US), Eyeshields, Gloves
GHS警示性声明 P261-P305 + P351 + P338
危险公开号 36/37/38
安全公开号 26
保存条件 under inert gas
保存温度 -20°C
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
PD-118057 is an activator of ether-a-go-go-related (hERG) potassium channel. PD-118057 is a second identified hERG channel activator, a representative in the series of structural analogs; PD-118057 at 10 μM leads to a 111% current increase in rabbit ventricular wedge (in comparison RPR260243 leads to only a 15% increase at the same concentration);PD-118057, unlike RPR260243, does not have a major effect on gating or kinetic properties of this channel. PD-118057prevents and reverses QT interval prolongation; Compounds such as PD-118057 may offer new approach in the treatment of delayed repolarization conditions, which occur in inherited or acquired long QT syndrome and congestive heart failure
详细说明 (简体中文)
Biochem/physiol Actions
PD-118057 is an activator of ether-a-go-go-related (hERG) potassium channel. PD-118057 is a second identified hERG channel activator, a representative in the series of structural analogs; PD-118057 at 10 μM leads to a 111% current increase in rabbit ventricular wedge (in comparison RPR260243 leads to only a 15% increase at the same concentration);PD-118057, unlike RPR260243, does not have a major effect on gating or kinetic properties of this channel. PD-118057prevents and reverses QT interval prolongation; Compounds such as PD-118057 may offer new approach in the treatment of delayed repolarization conditions, which occur in inherited or acquired long QT syndrome and congestive heart failure

参考文献